Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TTR | P02766 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 2/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1800550 | 0.79 | NPC1 (0.42) | KDM4EALDH1A1HPGDNOTUMMAPT | |
| SCHEMBL27808210 | 0.79 | TTR (0.46) | KDM4EALDH1A1POLBHPGDTTR | |
| SCHEMBL28701384 | 0.77 | KDM4E (0.42) | KDM4EALDH1A1POLBHPGDTTR | |
| SCHEMBL17867158 | 0.77 | SMN1; SMN2 (0.37) | KDM4EALDH1A1POLBHPGDTTR | |
| SCHEMBL11696604 | 0.76 | ALDH1A1 (0.42) | KDM4EALDH1A1TTRKMT2ANOTUM | |
| SCHEMBL3713109 | 0.74 | CYP1A2 (0.44) | KDM4EALDH1A1POLBHPGDKMT2A | |
| SCHEMBL11203114 | 0.73 | ALDH1A1 (0.42) | KDM4EALDH1A1POLBHPGDTTR | |
| SCHEMBL28288803 | 0.73 | ALDH1A1 (0.42) | KDM4EALDH1A1POLBHPGDKMT2A | |
| SCHEMBL10811729 | 0.72 | CYP3A4 (0.38) | ALDH1A1KMT2AMAPT | |
| SCHEMBL27569292 | 0.71 | KMT2A (0.42) | KDM4EALDH1A1POLBHPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431732-B | Polyether polyurethane foamed elastomer | 大使涂料(安徽)有限公司 | 2025-04-22 | — | — | CN | claimed |
| CN-119431732-A | Polyether polyurethane foaming elastomer and preparation method thereof | 大使涂料(安徽)有限公司 | 2025-02-14 | — | — | CN | claimed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| CN-119431732-B | Polyether polyurethane foamed elastomer | 大使涂料(安徽)有限公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-119431732-A | Polyether polyurethane foaming elastomer and preparation method thereof | 大使涂料(安徽)有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-116322616-A | Hair lightening compositions providing damage protection and sensory benefits and methods of use | 欧莱雅 | 2023-06-23 | — | — | CN | disclosed |
| US-11559474-B2 | Hair lightening compositions and methods of use | L'OREAL (FR) | 2023-01-24 | — | — | US | disclosed |
| CN-109721577-A | A kind of purification process of furans dicarboxylic acids | 中国科学院宁波材料技术与工程研究所 | 2019-05-07 | — | — | CN | disclosed |
| WO-2018119500-A1 | VISCOELASTIC COSMETIC COMPOSITIONS | L'OREAL (FR) | 2018-07-05 | — | — | WO | disclosed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | disclosed |
| US-20090103241-A1 | Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-04-23 | — | — | US | disclosed |
| US-20090028807-A1 | COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION | L'OREAL (FR) | 2009-01-29 | — | — | US | disclosed |
| CN-101347389-A | Cosmetic or pharmaceutical composition comprising a condensation polymer, cosmetic treatment method, condensation polymer and preparation method | OREAL (FR) | 2009-01-21 | — | — | CN | disclosed |
| CN-101184691-A | Electric double layer capacitor | SUMITOMO CHEMICAL CO (JP) | 2008-05-21 | — | — | CN | disclosed |
| CN-101180691-A | Electric double layer capacitor | SUMITOMO CHEMICAL CO (JP) | 2008-05-14 | — | — | CN | disclosed |
| US-20080094777-A1 | Electric double layer capacitor | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-04-24 | — | — | US | disclosed |
| EP-1905740-A1 | ELECTRIC DOUBLE LAYER CAPACITOR | Sumitomo Chemical Company, Limited (JP) | 2008-04-02 | — | — | EP | disclosed |
| EP-1876611-A1 | ELECTRIC DOUBLE LAYER CAPACITOR | Sumitomo Chemical Company, Limited (JP) | 2008-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090103241-A1 | Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 | CBR1, CYP24A1, CALU | KDM4E 2457/4885ALDH1A1 2159/4885POLB 1464/4885 |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | KDM4E 2504/4885ALDH1A1 1901/4885POLB 1148/4885 |
| US-20090028807-A1 | COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION | CUTA, SYMPK, TPRKB | KDM4E 1615/4885ALDH1A1 4765/4885POLB 245/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | KDM4E 1109/4885ALDH1A1 1510/4885POLB 705/4885 |
| US-11559474-B2 | Hair lightening compositions and methods of use | TYR, ALAD, CYBA | KDM4E 2585/4885ALDH1A1 448/4885POLB 156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.